Defended Mylan and Natco in suit alleging infringement of multiple patents related to polypeptide markers for measuring the molecular weight characteristics of a pharmaceutical composition for the treatment of multiple sclerosis.  Mylan obtained dismissal of suit in its entirety for failure to state a claim upon which relief could be granted.